Stocks
Health Care
hrtx
Heron Therapeutics
NASDAQ: HRTX
+0.03 (+2.63%)
1.365
USD
At close at Dec 10, 20:38 UTC
Income Statement
Revenue
144.28M
Gross Profit
105.64M
Operating Income
-11.53M
Pretax Income
-13.58M
Net Income
-13.58M
EBITDA
-8.61M
EBIT
-11.10M
Earnings Per Share
-0.09
Balance Sheet
Cash & Cash Equivalents
22.59M
Total Debt
178.47M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-36.34M
Book Value Per Share
-0.24
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.